1492 Capital Management’s Innophos Holdings, Inc. IPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-4,107
Closed -$222K 103
2017
Q1
$222K Sell
4,107
-265
-6% -$13.7K 0.17% 88
2016
Q4
$228K Sell
4,372
-1,258
-22% -$61.1K 0.18% 86
2016
Q3
$220K Sell
5,630
-129
-2% -$5.3K 0.18% 90
2016
Q2
$243K Buy
+5,759
New +$216K 0.22% 83
2015
Q1
Sell
-4,100
Closed -$240K 153
2014
Q4
$240K Hold
4,100
0.15% 106
2014
Q3
$226K Sell
4,100
-172
-4% -$9.98K 0.13% 108
2014
Q2
$246K Buy
+4,272
New +$233K 0.13% 112

Other funds holding IPHS

1492 Capital Management's IPHS Position: Q2 2017 in Review

1492 Capital Management sold out of Innophos Holdings, Inc. (IPHS) in Q2 2017, closing a stake of 4,107 shares — an estimated $222K sold.

1492 Capital Management first reported a position in IPHS in Q2 2014 and held it in 7 quarters. The position peaked at $246K in Q2 2014. 177 funds tracked by Wall St. Rank hold IPHS as of Q2 2017.

  • 1492 Capital Management reported no remaining Innophos Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
  • 1492 Capital Management sold 4,107 Innophos Holdings, Inc. shares in Q2 2017, an estimated $222K.
  • 1492 Capital Management first reported a position in Innophos Holdings, Inc. in Q2 2014 and held it in 7 quarters.
  • 1492 Capital Management's Innophos Holdings, Inc. position peaked at $246K in Q2 2014.
  • 177 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q2 2017.

Based on 1492 Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.